Literature DB >> 31476572

Modification of the base excision repair enzyme MBD4 by the small ubiquitin-like molecule SUMO1.

Mara Sannai1, Valentina Doneddu2, Veda Giri1, Steven Seeholzer3, Emmanuelle Nicolas1, Shu-Chin Yip4, Maria Rosaria Bassi1, Pietro Mancuso1, Salvatore Cortellino1, Antonio Cigliano1, Rebecca Lurie1, Hua Ding3, Jonathan Chernoff4, Robert W Sobol5, Timothy J Yen4, Luigi Bagella6, Alfonso Bellacosa7.   

Abstract

The base excision repair DNA N-glycosylase MBD4 (also known as MED1), an interactor of the DNA mismatch repair protein MLH1, plays a central role in the maintenance of genomic stability of CpG sites by removing thymine and uracil from G:T and G:U mismatches, respectively. MBD4 is also involved in DNA damage response and transcriptional regulation. The interaction with other proteins is likely critical for understanding MBD4 functions. To identify novel proteins that interact with MBD4, we used tandem affinity purification (TAP) from HEK-293 cells. The MBD4-TAP fusion and its co-associated proteins were purified sequentially on IgG and calmodulin affinity columns; the final eluate was shown to contain MLH1 by western blotting, and MBD4-associated proteins were identified by mass spectrometry. Bands with molecular weight higher than that expected for MBD4 (˜66 kD) yielded peptides corresponding to MBD4 itself and the small ubiquitin-like molecule-1 (SUMO1), suggesting that MBD4 is sumoylated in vivo. MBD4 sumoylation was validated by co-immunoprecipitation in HEK-293 and MCF7 cells, and by an in vitrosumoylation assay. Sequence and mutation analysis identified three main sumoylation sites: MBD4 is sumoylated preferentially on K137, with additional sumoylation at K215 and K377. Patterns of MBD4 sumoylation were altered, in a DNA damage-specific way, by the anti-metabolite 5-fluorouracil, the alkylating agent N-Methyl-N-nitrosourea and the crosslinking agent cisplatin. MCF7 extract expressing sumoylated MBD4 displays higher thymine glycosylase activity than the unmodified species. Of the 67 MBD4 missense mutations reported in The Cancer Genome Atlas, 14 (20.9%) map near sumoylation sites. These results indicate that MBD4 is sumoylated in vivo in a DNA damage-specific manner, and suggest that sumoylation serves to regulate its repair activity and could be compromised in cancer. This study expands the role played by sumoylation in fine-tuning DNA damage response and repair.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA damage; MBD4/MED1; SUMO1; Sumoylation

Mesh:

Substances:

Year:  2019        PMID: 31476572      PMCID: PMC6785017          DOI: 10.1016/j.dnarep.2019.102687

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  65 in total

1.  Tandem affinity purification of protein complexes from mammalian cells.

Authors:  D M Cox; M Du; X Guo; K W M Siu; J C McDermott
Journal:  Biotechniques       Date:  2002-08       Impact factor: 1.993

Review 2.  The fast-growing business of SUMO chains.

Authors:  Helle D Ulrich
Journal:  Mol Cell       Date:  2008-11-07       Impact factor: 17.970

3.  Specific binding of a designed pyrrolidine abasic site analog to multiple DNA glycosylases.

Authors:  O D Schärer; H M Nash; J Jiricny; J Laval; G L Verdine
Journal:  J Biol Chem       Date:  1998-04-10       Impact factor: 5.157

4.  Modification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnover.

Authors:  Ulrike Hardeland; Roland Steinacher; Josef Jiricny; Primo Schär
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

Review 5.  SUMO-specific proteases and isopeptidases of the SENP family at a glance.

Authors:  Kathrin Kunz; Tanja Piller; Stefan Müller
Journal:  J Cell Sci       Date:  2018-03-20       Impact factor: 5.285

6.  Analysis of PTP1B sumoylation.

Authors:  Sayanti Saha; Jonathan Chernoff
Journal:  Methods       Date:  2013-09-25       Impact factor: 3.608

Review 7.  The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.

Authors:  Jaclyn R Gareau; Christopher D Lima
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12       Impact factor: 94.444

8.  5-halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2).

Authors:  Victoria Valinluck; Pingfang Liu; Joseph I Kang; Artur Burdzy; Lawrence C Sowers
Journal:  Nucleic Acids Res       Date:  2005-05-25       Impact factor: 16.971

9.  Complex relationship between mismatch repair proteins and MBD4 during immunoglobulin class switch recombination.

Authors:  Fernando Grigera; Alfonso Bellacosa; Amy L Kenter
Journal:  PLoS One       Date:  2013-10-29       Impact factor: 3.240

10.  Thymine DNA glycosylase as a novel target for melanoma.

Authors:  Pietro Mancuso; Rossella Tricarico; Vikram Bhattacharjee; Laura Cosentino; Yuwaraj Kadariya; Jaroslav Jelinek; Emmanuelle Nicolas; Margret Einarson; Neil Beeharry; Karthik Devarajan; Richard A Katz; Dorjbal G Dorjsuren; Hongmao Sun; Anton Simeonov; Antonio Giordano; Joseph R Testa; Guillaume Davidson; Irwin Davidson; Lionel Larue; Robert W Sobol; Timothy J Yen; Alfonso Bellacosa
Journal:  Oncogene       Date:  2019-01-23       Impact factor: 8.756

View more
  1 in total

Review 1.  Noncatalytic Domains in DNA Glycosylases.

Authors:  Natalia A Torgasheva; Evgeniia A Diatlova; Inga R Grin; Anton V Endutkin; Grigory V Mechetin; Ivan P Vokhtantsev; Anna V Yudkina; Dmitry O Zharkov
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.